LIGAND PHARMACEUTICALS INCORPORATED
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -0.5% | -0.5% | -0.3% |
| FY2017 | 3.1% | 3.1% | 1.9% |
| FY2018 | 25.6% | 25.6% | 11.4% |
| FY2019 | 82.0% | 82.0% | 42.1% |
| FY2020 | -0.4% | -0.4% | -0.2% |
| FY2021 | 7.0% | 7.0% | 4.4% |
| FY2022 | -5.6% | -5.6% | -4.4% |
| FY2023 | 7.4% | 7.4% | 6.6% |
| FY2024 | -0.5% | -0.5% | -0.4% |
| FY2025 | 12.2% | 12.2% | 8.0% |